Tag: PET

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Pet Oral Care Products Market size & share revenue was valued at approximately USD 2,056.87 Million in 2024 and is expected to reach USD 2,169.79 Million in 2025 and is expected to reach around USD 3,583.11 Million by 2034, at a CAGR of 5.73% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are All4pets, AllAccem Inc., Central Garden & Pet Company, Ceva, Ceva Santé Animale, Cosmos Corporation, Dechra Pharmaceuticals plc, Goran Pharma Pvt. Ltd., Hill’s Pet Nutrition Inc., Imrex Inc., Kane Biotech, Inc., Mars Incorporated, Nestlé Purina PetCare Company (Nestlé S.A.), Petzlife UK, Vetoquinol SA, Virbac and others.

Investors can contact the law firm at no cost to learn more about recovering their losses

MELBOURNE, Australia and INDIANAPOLIS, July 10, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that its next-generation PSMA¹ PET² imaging agent, Gozellix® (kit for the preparation of gallium-68 (⁶⁸Ga) gozetotide injection), has been granted a permanent Healthcare Common Procedure Coding System (HCPCS) code by the U.S. Centers for Medicare & Medicaid Services (CMS).

Corbion, a global leader in sustainable ingredient solutions, has successfully secured multiple regulatory approvals from China’s General Administration of Customs (GACC) paving the way for offering Corbion’s high quality, sustainable, algae-derived omega-3 DHA solutions in China’s fast-growing human and animal nutrition segments.